## Clinical Context: AF with RVR Causing Acute Decompensated Heart Failure This patient presents with **acute decompensated heart failure (AHF) secondary to AF with RVR**. Critical features: - Severe dyspnea, orthopnea, bilateral basal crackles, pulmonary edema on CXR - BP **165/95 mmHg** — patient is **hypertensive, NOT hypotensive** - HR 140 bpm (irregular), elevated JVP - Mildly elevated troponin (demand ischemia/myocardial stress) **Key Point:** This patient is **hemodynamically STABLE** (BP 165/95 mmHg, no hypotension, no shock, no altered mental status). The pulmonary edema is a consequence of the rapid ventricular rate and underlying structural disease, but the patient is NOT in cardiogenic shock. In this setting, the priority is **rate control + diuresis**, not immediate cardioversion. ## Why IV Amiodarone + Diuretics is Correct ### Hemodynamic Status Determines Management | Scenario | Intervention | |---|---| | AF + hypotension/shock/cardiogenic shock | **Immediate synchronized cardioversion** | | AF + RVR + pulmonary edema + **preserved/elevated BP** (hemodynamically stable) | **IV amiodarone + diuretics** | | AF + RVR + stable hemodynamics + no structural disease | IV CCB or beta-blocker | | Chronic stable AF | Oral rate control + anticoagulation | **High-Yield:** In AF with RVR complicated by acute heart failure but **without hemodynamic instability (hypotension, shock)**, IV amiodarone is the preferred agent because: 1. It provides **rate control** (AV nodal slowing) within 15–30 minutes 2. It has **mild negative inotropy** — safer than diltiazem/beta-blockers in reduced EF 3. It may achieve **chemical cardioversion** over hours 4. Combined with **IV furosemide**, it addresses both the rate and the volume overload [Harrison's Principles of Internal Medicine, 21e, Ch. 226; ESC AF Guidelines 2020] ### Why IV Amiodarone is Preferred Over IV Diltiazem in HF - **Diltiazem (Option C):** Calcium channel blockers are **contraindicated or relatively contraindicated in AF with reduced EF / decompensated HF** due to their negative inotropic effects, which can worsen cardiac output and precipitate cardiogenic shock. In a patient with pulmonary edema and likely underlying structural heart disease, diltiazem is hazardous. - **IV Amiodarone (Option B):** Preferred for rate control in AF with decompensated HF or reduced EF — it is the agent of choice per ACC/AHA and ESC guidelines in this scenario. ## Why Other Options Are Incorrect - **Option A (Oral amiodarone 200 mg):** Oral loading is far too slow (hours to days) for an acutely decompensated patient requiring immediate rate control. Inappropriate in the acute setting. - **Option C (IV diltiazem + furosemide):** Diltiazem is contraindicated in decompensated HF with reduced EF due to negative inotropy. While furosemide is appropriate, diltiazem is the wrong rate-control agent here. - **Option D (Synchronized cardioversion):** Cardioversion is indicated for **hemodynamically UNSTABLE** AF — defined as hypotension, cardiogenic shock, altered consciousness, or acute coronary syndrome refractory to medical therapy. This patient has **elevated BP (165/95)**, making her hemodynamically stable. Immediate cardioversion without adequate anticoagulation (AF diagnosed 3 months ago, anticoagulation status unclear) also carries significant stroke risk. Medical stabilization with rate control and diuresis is the appropriate first step. ## Management Summary 1. **IV amiodarone** (300 mg bolus over 20–60 min, then infusion) — rate control ± chemical cardioversion 2. **IV furosemide** — relieve pulmonary congestion 3. **Anticoagulation** — ensure therapeutic coverage before any cardioversion attempt 4. **Monitor** — reassess hemodynamics; if patient deteriorates to shock/hypotension, proceed to cardioversion **Clinical Pearl:** The distinction between "hemodynamically unstable" and "hemodynamically compromised but stable" is critical. Pulmonary edema alone with preserved/elevated BP = stable → medical management first. Hypotension + pulmonary edema = unstable → immediate cardioversion. (ESC AF Guidelines 2020; Harrison 21e)
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.